Good day and thank you for standing by. Welcome to the NewtekOne, Inc. Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Get key highlights from BridgeBio Pharma’s Q3 2025 earnings: record Attruby sales, positive Phase III results, and strategic outlook for market share growth.
The new funds build on the success of BRIM, established in April 2024 with an initial investment mandate from PIF ...
Sommige resultaten zijn verborgen omdat ze mogelijk niet toegankelijk zijn voor u.
Niet-toegankelijke resultaten weergeven
Feedback